Structural Insights into TOR Signaling

The Target of Rapamycin (TOR) is a highly conserved serine/threonine protein kinase that performs essential roles in the control of cellular growth and metabolism. TOR acts in two distinct multiprotein complexes, TORC1 and TORC2 (mTORC1 and mTORC2 in humans), which maintain different aspects of cell...

Full description

Bibliographic Details
Main Authors: Lucas Tafur, Jennifer Kefauver, Robbie Loewith
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/11/8/885
id doaj-adc5e089570040a78b6b52dd8073d391
record_format Article
spelling doaj-adc5e089570040a78b6b52dd8073d3912020-11-25T03:56:12ZengMDPI AGGenes2073-44252020-08-011188588510.3390/genes11080885Structural Insights into TOR SignalingLucas Tafur0Jennifer Kefauver1Robbie Loewith2Department of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, SwitzerlandDepartment of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, SwitzerlandDepartment of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, SwitzerlandThe Target of Rapamycin (TOR) is a highly conserved serine/threonine protein kinase that performs essential roles in the control of cellular growth and metabolism. TOR acts in two distinct multiprotein complexes, TORC1 and TORC2 (mTORC1 and mTORC2 in humans), which maintain different aspects of cellular homeostasis and orchestrate the cellular responses to diverse environmental challenges. Interest in understanding TOR signaling is further motivated by observations that link aberrant TOR signaling to a variety of diseases, ranging from epilepsy to cancer. In the last few years, driven in large part by recent advances in cryo-electron microscopy, there has been an explosion of available structures of (m)TORC1 and its regulators, as well as several (m)TORC2 structures, derived from both yeast and mammals. In this review, we highlight and summarize the main findings from these reports and discuss both the fascinating and unexpected molecular biology revealed and how this knowledge will potentially contribute to new therapeutic strategies to manipulate signaling through these clinically relevant pathways.https://www.mdpi.com/2073-4425/11/8/885target of rapamycinstructural biologycell growth homeostasis
collection DOAJ
language English
format Article
sources DOAJ
author Lucas Tafur
Jennifer Kefauver
Robbie Loewith
spellingShingle Lucas Tafur
Jennifer Kefauver
Robbie Loewith
Structural Insights into TOR Signaling
Genes
target of rapamycin
structural biology
cell growth homeostasis
author_facet Lucas Tafur
Jennifer Kefauver
Robbie Loewith
author_sort Lucas Tafur
title Structural Insights into TOR Signaling
title_short Structural Insights into TOR Signaling
title_full Structural Insights into TOR Signaling
title_fullStr Structural Insights into TOR Signaling
title_full_unstemmed Structural Insights into TOR Signaling
title_sort structural insights into tor signaling
publisher MDPI AG
series Genes
issn 2073-4425
publishDate 2020-08-01
description The Target of Rapamycin (TOR) is a highly conserved serine/threonine protein kinase that performs essential roles in the control of cellular growth and metabolism. TOR acts in two distinct multiprotein complexes, TORC1 and TORC2 (mTORC1 and mTORC2 in humans), which maintain different aspects of cellular homeostasis and orchestrate the cellular responses to diverse environmental challenges. Interest in understanding TOR signaling is further motivated by observations that link aberrant TOR signaling to a variety of diseases, ranging from epilepsy to cancer. In the last few years, driven in large part by recent advances in cryo-electron microscopy, there has been an explosion of available structures of (m)TORC1 and its regulators, as well as several (m)TORC2 structures, derived from both yeast and mammals. In this review, we highlight and summarize the main findings from these reports and discuss both the fascinating and unexpected molecular biology revealed and how this knowledge will potentially contribute to new therapeutic strategies to manipulate signaling through these clinically relevant pathways.
topic target of rapamycin
structural biology
cell growth homeostasis
url https://www.mdpi.com/2073-4425/11/8/885
work_keys_str_mv AT lucastafur structuralinsightsintotorsignaling
AT jenniferkefauver structuralinsightsintotorsignaling
AT robbieloewith structuralinsightsintotorsignaling
_version_ 1724466419826950144